2020 Global Call To Action
FH Europe and the European Atherosclerosis Society (EAS) participated in an international coalition convened by the FH Foundation, Pasadena, California and the World Heart Federation, Geneva, Switzerland to reexamine and update key recommendations issued by the World Health Organization (WHO) in their Report on Familial Hypercholesterolemia in 1998. In the more than 20 years since that report, few of these recommendations have been systematically implemented on a country-by-country basis, leaving 9 out of 10 people born with FH undiagnosed. Now FH Europe and the EAS as a result of this collaboration with global stakeholders announce the publication of Global Call to Action to tackle the global burden of Familial Hypercholesterolaemia (FH).
Publication in more European languages coming soon
Find out more about Familial Hypercholesterolemia, symptoms, types of the condition and the latest treatment options.
See FH patient organisations active across Europe who form part of our Network. Find the one in your country and learn more about the support, activities & events available close to you and in your language
Keep In Touch
Join our mailing list and follow us on Social Media to be informed about when and in what other European languages the Global Call to Action is available.
FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt